Perspective Therapeutics Inc (NYSE American:CATX)
| 0.5104 Delayed Data As of May 26 |  +0.0116 / +2.33%Today’s Change | 0.19 Today|||52-Week Range 0.70 | +106.56% Year-to-Date |
Latest CATX News | Press Releases
No recent news for Perspective Therapeutics Inc.
Today’s Trading
| Previous close | 0.50 |
| Today’s open | 0.52 |
| Day’s range | 0.50 - 0.52 |
| Volume | 118,810 |
| Average volume (3 months) | 569,561 |
| Market cap | $142.9M |
Data as of 3:45pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -57.06% |
| Earnings growth (this year) | -202.00% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +7.38% |
| P/E ratio | NM |
| Price/Sales | 4.06 |
| Price/Book | 1.18 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OGIOrganiGram Holdings ... | -0.01 | -2.37% |
| CDTXCidara Therapeutics ... | +0.07 | +5.47% |
| ---- | ||
| --Allergy Therapeutics... | 0.00 | 0.00% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | September 26, 2023 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $10.8M |
| Annual profit (last year) | -$7.3M |
| Net profit margin | -67.36% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Richland, Washington |
Forecasts
